Ledger.Open graph →
SEC Form D · filed April 8, 2024

Praesidia Biotherapeutics, Inc

Offering
$15.0M
Sold
$500K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ARLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Sohang Chatterjee · Arlington, MAExec · DirectorMartin Lehr · Philadelphia, PADirectorPradip Majumder · Arlington, MAExecShawn Titcomb · Lauderdale by the Sea, FLDirectorClayton M. Olson · VANCOUVER, British Columbia, CanadaExecMichael Blady · VANCOUVER, British Columbia, CanadaDirectorDal C. Reid · Amarillo, TXExec · DirectorDouglas J. Crozier · Amarillo, TXDirectorKevin Logan · San Francisco, CADirectorCurtis A. Lockshin · Marlborough, MAExecRobert J. Bitterman · Marlborough, MADirectorRobert A. Ferrara · Marlborough, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗